These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical outcomes at 9-10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome. Carroll BJ; Ostrenga JS; Fink AK; Antos NJ; Cromwell EA; Ren CL Pediatr Pulmonol; 2024 Jun; 59(6):1606-1613. PubMed ID: 38477633 [TBL] [Abstract][Full Text] [Related]
23. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study. Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956 [TBL] [Abstract][Full Text] [Related]
29. Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening. Ratti GA; Fernandez GS; Schechter MS; Stalvey MS; Ostrenga J; Fink AK; Jain R J Cyst Fibros; 2022 Sep; 21(5):784-791. PubMed ID: 35086791 [TBL] [Abstract][Full Text] [Related]
30. Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary Outcomes. Rosenfeld M; Ostrenga J; Cromwell EA; Magaret A; Szczesniak R; Fink A; Schechter MS; Faro A; Ren CL; Morgan W; Sanders DB JAMA Pediatr; 2022 Oct; 176(10):990-999. PubMed ID: 35913705 [TBL] [Abstract][Full Text] [Related]
31. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry. Salinas DB; Wee CP; Bailey B; Raraigh K; Conrad D Ann Am Thorac Soc; 2023 Apr; 20(4):523-531. PubMed ID: 36409994 [No Abstract] [Full Text] [Related]
32. Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry. Godfrey EM; Mody S; Schwartz MR; Heltshe SL; Taylor-Cousar JL; Jain R; Sufian S; Josephy T; Aitken ML Contraception; 2020 Jun; 101(6):420-426. PubMed ID: 32109430 [TBL] [Abstract][Full Text] [Related]
33. Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience. Şaşihüseyinoğlu AŞ; Altıntaş DU; Bişgin A; Doğruel D; Yılmaz M; Serbes M Turk J Pediatr; 2019; 61(4):505-512. PubMed ID: 31990467 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of diagnostic data after introduction of cystic fibrosis screening in newborns in Germany]. Nährlich L; Brockow I Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1243-1248. PubMed ID: 37831094 [TBL] [Abstract][Full Text] [Related]
35. Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms. Vernooij-van Langen AM; Gerzon FL; Loeber JG; Dompeling E; Dankert-Roelse JE Mol Genet Metab; 2014; 113(1-2):100-4. PubMed ID: 25077434 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States. Goss CH; Sykes J; Stanojevic S; Marshall B; Petren K; Ostrenga J; Fink A; Elbert A; Quon BS; Stephenson AL Am J Respir Crit Care Med; 2018 Mar; 197(6):768-775. PubMed ID: 29099606 [TBL] [Abstract][Full Text] [Related]
37. Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States. McGarry ME; Huang CY; Nielson DW; Ly NP J Cyst Fibros; 2021 May; 20(3):424-431. PubMed ID: 33162303 [TBL] [Abstract][Full Text] [Related]